Forearm vascular responses to serotonin are not mediated by products of cyclooxygenase

British Journal of Clinical Pharmacology

Volumn 41, Issue 3, 1996, Pages 241-243

  Nugent, A G ^a   McGurk, C ^a   Johnston, G D ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Cyclooxygenase; Forearm blood flow; Indomethacin; Inhibition; Serotonin

Indexed keywords

INDOMETACIN; PROSTAGLANDIN SYNTHASE; SEROTONIN;

ADULT; ARTICLE; DRUG BLOOD LEVEL; ENZYME ACTIVITY; ENZYME INHIBITION; FOREARM BLOOD FLOW; HUMAN; HUMAN EXPERIMENT; INTRAARTERIAL DRUG ADMINISTRATION; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PLETHYSMOGRAPHY; PRIORITY JOURNAL; VASOCONSTRICTION; VASODILATATION; VEIN OCCLUSION; VOLUNTEER;

EID: 0029969486     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2125.1996.tb00189.x     Document Type: Article

References (15)

1. Van Nueten JM, Janssens WJ, Vanhoutte PM. Serotonin and vascular smooth muscle. In Serotonin and the cardiovascular system, First Edition, editor Vanhoutte PM. Raven Press, 1985; 95-103.
2. Cohen RA, Shepherd JT, Vanhoutte PM. 5-Hydroxytryptamine can mediate endothelium-dependent relaxation of coronary arteries. Am J Physiol 1983; 245: H1077-H1080.
3. Klockenbusch W, Braun MS, Schroder H, Heckenberger RE, Strobach H, Schror K. Prostacyclin rather than nitric oxide lowers human umbilical artery tone in vitro. Eur J Obstet Gynaecol Reproductive Biol 1992; 47: 109-115.
4. Rosenblum WI, Nelson GH. Endothelium-dependent constriction demonstrated in vivo in mouse cerebral arterioles. Circulation Res 1988; 63: 837-843.
5. Blauw GJ, van Brummelen P, Bruning T, van Zwieten PA. Local haemodynamic effects of serotonin and ketanserin in healthy subjects: studies in the forearm. J Cardiovasc Pharmacol 1988; 11(Suppl. 1): S41-S43.
6. Roddie IC, Shepherd JT, Whelan RF. The action of 5-hydroxytryptamine on the blood vessels of the human hand and forearm. Br J Pharmacol 1955; 10: 445-450.
7. 3-receptor. J Cardiovasc Pharmacol 1993; 22: 44-51.
8. 1A receptors in nitric oxide-dependent vasodilatation caused by serotonin in the human forearm vascular bed. J Cardiovasc Pharmacol 1994; 24: 454-461.
9. Niopas I, Mamzoridi K. Determination of indomethacin and mefenamic acid in plasma by high-performance liquid chromatography. J Chromatogr 1994; 656: 447-450.
10. Rane A, Oelz O, Frolich JC, et al. Relation between plasma concentration of indomethacin and its effect on prostaglandin synthesis and platelet aggregation in men. Clin Pharmacol Ther 1978; 23: 658-668.
11. Miranda FJ, Torregrosa G, Salom JB, et al. Endothelial modulation of 5-hydroxytryptamine-induced contraction in goat cerebral arteries. Gen Pharmacol 1993; 24: 649-653.
12. Seager JM, Clark AH, Garland CJ. Endothelium-dependent contractile responses to 5-hydroxytryptamine in the rabbit basilar artery. Br J Pharmacol 1992; 105: 424-428.
13. Auch-Schwelk W, Vanhoutte PM. Endothelium-derived contracting factor released by serotonin in the aorta of the spontaneously hypertensive rat. Am J Hypertension 1991; 4: 769-772.
14. Golino P, Piscione F, Willerson JT et al. Divergent effects of serotonin on coronary artery dimensions and blood flow in patients with coronary atherosclerosis and control patients. New Eng J Med 1991; 324: 641-648.
15. McFadden EP, Clarke JG, Davies GJ, Kaski JC, Haider AW, Maseri A. Effects of intracoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina. New Eng J Med 1991; 324: 648-654.